[Skip to Content]


#makemydatacount – Secure national audit funding to protect patient safety and professional standards

We are calling on all those involved in funding and running national clinical audits to support our campaign #makemydatacount. National clinical audits are important to measure how care is being delivered and how medical professionals are delivering that care to the highest standards possible. National audits are developed and continually improved to measure performance and

NICE publishes serious eye disorders quality standard

The Royal College of Ophthalmologists supports the quality standard but believes the implementation will be challenging for the overwhelmed hospital eye service.  The National Institute for Health and Care Excellence (NICE) has published its first quality standard looking at serious eye disorders, covering the diagnosis and management of cataracts, glaucoma and age-related macular degeneration (AMD)

Workshop Review: National Ophthalmology Database (NOD) workshop

This was a one day workshop held on Wednesday 21 February 2018, chaired by Professor John Sparrow, Clinical lead for NOD audit. The day was a means of information and debate and included topics covering the origins of the audit and recommendations to support data validation and completeness.  The risk indicators and risk model /adjustments were

Contributing surgeons and centres must validate their cataract audit data on the NOD audit website before Wednesday, 7 March 2018

The data analysis has been completed for the second prospective audit data collection period, 01 September 2016 to 31 August 2017. Contributing surgeons and centres can now view their data behind the login on the NOD audit website prior to inclusion in the Audit annual report and the Clinical Outcomes Publication. The NOD team encourages

    • Page Tags | NOD

Audit and Data

Clinical effectiveness is one of the three arms of healthcare quality and can be defined as “Care which provides good outcomes, that is good results or success of care for patients.  This can be assessed both through clinical outcome measures, such as mortality/survival rates, complication rates, and through patient reported outcome measures (PROMs) such as